175 related articles for article (PubMed ID: 19664376)
1. Fibrate therapy and renal function.
Sica DA
Curr Atheroscler Rep; 2009 Sep; 11(5):338-42. PubMed ID: 19664376
[TBL] [Abstract][Full Text] [Related]
2. Fibrate therapy: an update.
Remick J; Weintraub H; Setton R; Offenbacher J; Fisher E; Schwartzbard A
Cardiol Rev; 2008; 16(3):129-41. PubMed ID: 18414184
[TBL] [Abstract][Full Text] [Related]
3. [Fibrate-induced deterioration of renal function].
Polanco N; Hernández E; González E; Gutiérrez Martínez E; Bello I; Gutiérrez-Millet V; García F; Morales E; Praga M
Nefrologia; 2009; 29(3):208-13. PubMed ID: 19554053
[TBL] [Abstract][Full Text] [Related]
4. Safety considerations with fibrate therapy.
Davidson MH; Armani A; McKenney JM; Jacobson TA
Am J Cardiol; 2007 Mar; 99(6A):3C-18C. PubMed ID: 17368275
[TBL] [Abstract][Full Text] [Related]
5. New fibrate use and acute renal outcomes in elderly adults: a population-based study.
Zhao YY; Weir MA; Manno M; Cordy P; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Moist L; Parikh CR; Paterson JM; Wald R; Yao Z; Garg AX
Ann Intern Med; 2012 Apr; 156(8):560-9. PubMed ID: 22508733
[TBL] [Abstract][Full Text] [Related]
6. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
[TBL] [Abstract][Full Text] [Related]
7. Deterioration in renal function associated with fibrate therapy.
Lipscombe J; Lewis GF; Cattran D; Bargman JM
Clin Nephrol; 2001 Jan; 55(1):39-44. PubMed ID: 11200866
[TBL] [Abstract][Full Text] [Related]
8. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
9. Fibrates and renal function.
Gajdos M; Dzúrik R
Clin Nephrol; 2003 Jul; 60(1):65-6. PubMed ID: 12872864
[No Abstract] [Full Text] [Related]
10. Atherosclerosis in type 2 diabetes: a role for fibrate therapy?
Steiner G
Diab Vasc Dis Res; 2007 Dec; 4(4):368-74. PubMed ID: 18158710
[TBL] [Abstract][Full Text] [Related]
11. Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C.
Ncube V; Starkey B; Wang T
Ann Clin Biochem; 2012 Sep; 49(Pt 5):491-3. PubMed ID: 22829698
[TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
[TBL] [Abstract][Full Text] [Related]
13. 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients.
Shaish A; Harari A; Hananshvili L; Cohen H; Bitzur R; Luvish T; Ulman E; Golan M; Ben-Amotz A; Gavish D; Rotstein Z; Harats D
Atherosclerosis; 2006 Nov; 189(1):215-21. PubMed ID: 16413556
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
Devroey D; Velkeniers B; Duquet W; Betz W
Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate and the kidney: an overview.
Kostapanos MS; Florentin M; Elisaf MS
Eur J Clin Invest; 2013 May; 43(5):522-31. PubMed ID: 23480615
[TBL] [Abstract][Full Text] [Related]
16. Fibrates and estimated glomerular filtration rate: observations from an outpatient clinic setting and clinical implications.
Abbas A; Saraf S; Ramachandran S; Raju J; Ramachandran S
Postgrad Med J; 2012 Sep; 88(1043):503-6. PubMed ID: 22460858
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate: altered renal function.
Prescrire Int; 2011 Jun; 20(117):154-5. PubMed ID: 21682015
[TBL] [Abstract][Full Text] [Related]
18. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study.
Papadakis MA; Arieff AI
Am J Med; 1987 May; 82(5):945-52. PubMed ID: 3578363
[TBL] [Abstract][Full Text] [Related]
19. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
[TBL] [Abstract][Full Text] [Related]
20. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
Pachon J; Lorber MI; Bia MJ
Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
